Literature DB >> 9217586

Compliance with treatment regimens in chronic asymptomatic diseases.

N H Miller1.   

Abstract

At least one third of hospital admissions for heart failure result from noncompliance with therapeutic regimens, both dietary and pharmacologic. In chronic diseases, noncompliance with both lifestyle modification and medication regimens is a major health problem. Patients frequently stop taking their medications because they consider them ineffective or because they experience unpleasant side effects. In asymptomatic conditions, patients may believe they do not need the medication and may not even fill their prescription. If they do obtain the medications, they may forget to take them regularly. Educational efforts and behavioral techniques can improve patient compliance in chronic, asymptomatic conditions, but one of the most effective strategies remains improved patient-physician communication.

Entities:  

Mesh:

Year:  1997        PMID: 9217586     DOI: 10.1016/s0002-9343(97)00467-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  78 in total

1.  Individualized stepped care of chronic illness.

Authors:  M Von Korff; B Tiemens
Journal:  West J Med       Date:  2000-02

Review 2.  Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations.

Authors:  Ronald Emkey
Journal:  MedGenMed       Date:  2004-07-19

Review 3.  Adherence to treatment of osteoporosis: a need for study.

Authors:  F Lekkerkerker; J A Kanis; N Alsayed; G Bouvenot; N Burlet; D Cahall; A Chines; P Delmas; R-L Dreiser; D Ethgen; N Hughes; J-M Kaufman; S Korte; G Kreutz; A Laslop; B Mitlak; V Rabenda; R Rizzoli; A Santora; R Schimmer; Y Tsouderos; P Viethel; J-Y Reginster
Journal:  Osteoporos Int       Date:  2007-06-22       Impact factor: 4.507

Review 4.  Review of adherence to medications for the treatment of osteoporosis.

Authors:  Deborah T Gold; Stuart Silverman
Journal:  Curr Osteoporos Rep       Date:  2006-03       Impact factor: 5.096

Review 5.  Medication adherence: a call for action.

Authors:  Hayden B Bosworth; Bradi B Granger; Phil Mendys; Ralph Brindis; Rebecca Burkholder; Susan M Czajkowski; Jodi G Daniel; Inger Ekman; Michael Ho; Mimi Johnson; Stephen E Kimmel; Larry Z Liu; John Musaus; William H Shrank; Elizabeth Whalley Buono; Karen Weiss; Christopher B Granger
Journal:  Am Heart J       Date:  2011-09       Impact factor: 4.749

6.  Depression, medication adherence, and service utilization in systemic lupus erythematosus.

Authors:  Laura J Julian; Edward Yelin; Jinoos Yazdany; Pantelis Panopalis; Laura Trupin; Lindsey A Criswell; Patricia Katz
Journal:  Arthritis Rheum       Date:  2009-02-15

7.  Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis.

Authors:  D L Kendler; J D Ringe; L-G Ste-Marie; B Vrijens; E B Taylor; P D Delmas
Journal:  Osteoporos Int       Date:  2009-03-19       Impact factor: 4.507

8.  Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience.

Authors:  K Briot; P Ravaud; P Dargent-Molina; M Zylberman; S Liu-Leage; C Roux
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

9.  The evolution of transdermal/ topical overactive bladder therapy and its benefits over oral therapy.

Authors:  Scott A Macdiarmid
Journal:  Rev Obstet Gynecol       Date:  2009

10.  Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.

Authors:  X Wu; D Wei; B Sun; X N Wu
Journal:  Osteoporos Int       Date:  2016-09-13       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.